T
Theravance Biopharma Inc
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 10, 2026(ET)
Revenue
This quarter$22M
Analyst estimate$22M▲ +0.0%
Year ago (Sep '25)$20M▲ +9.8%
Revenue Growth Trajectory
-21%YoY
Last 6 quarters
Analyst consensus · $23M · 3 analysts
As of 8/25, 00:02 KST